Screener
HealthEquity HQY D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026. Open the filing →
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
FAQ
- What is HealthEquity's D&A?
- HealthEquity (HQY) reported D&A of $38.21M in Q1 2026.
- How has HealthEquity's D&A changed year-over-year?
- HealthEquity's D&A decreased by 1.4% year-over-year, from $38.74M to $38.21M.
- What is the long-term trend for HealthEquity's D&A?
- Over 4 years (2022 to 2026), HealthEquity's D&A has grown at a 3.0% compound annual growth rate (CAGR), from $137.19M to $154.66M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about HealthEquity's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude